<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03628690</url>
  </required_header>
  <id_info>
    <org_study_id>Protocol: ERM-001, Version 01</org_study_id>
    <nct_id>NCT03628690</nct_id>
  </id_info>
  <brief_title>A Post-Market Study of BandGrip in Traumatic Wound Closure Compared to Suture</brief_title>
  <official_title>A Post-Market Study of BandGrip in Traumatic Wound Closure Compared to Suture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BandGrip</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BandGrip</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      an unbalanced (2:1) randomized study comparing two methods of traumatic skin closure in an ER&#xD;
      setting: BandGrip vs suture&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up to 45 subjects at up to 2 study sites who present to the ER for treatment of a skin&#xD;
      laceration will be consented and randomized to treatment with suture or BandGrip. Subjects&#xD;
      will be followed for 30 days post treatment to assess cosmetic quality of wound healing,&#xD;
      evidence of adverse events related to closure method, and speed and completeness of wound&#xD;
      closure and removal of closure devices.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 15, 2018</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2:1 randomization</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete wound closure</measure>
    <time_frame>30 days post treatment</time_frame>
    <description>defined as continuous approximation of skin margins without need for reintervention .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wound comesis</measure>
    <time_frame>10 and 30 days post closure</time_frame>
    <description>a 100mm visual analog scale (with 100 representing complete satisfaction with comesis) assessing wound cosmesis using the Comesis Visual Analog Scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain/discomfort</measure>
    <time_frame>index procedure and 10 days post closure</time_frame>
    <description>The subject will complete a 100mm visual analog scale with 100 representing worst pain level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection</measure>
    <time_frame>10 and 30 days post closure</time_frame>
    <description>incidence of clinical infection requiring antibiotic treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject satisfaction</measure>
    <time_frame>30 days post closure</time_frame>
    <description>subjects will complete a 100mm VAS (with 100 representing complete satisfaction) to evaluate their overall assessment of their scar,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician satisfaction</measure>
    <time_frame>index procedure</time_frame>
    <description>a 100mm VAS ( with 100mm representing complete satisfaction) to evaluate the overall ease of wound closure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to wound closure and device removal</measure>
    <time_frame>index procedure and 10 days post wound closure</time_frame>
    <description>Time to closure and removal of closure device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Satisfaction</measure>
    <time_frame>30 days post closure</time_frame>
    <description>indication of subject preference for method of sound closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound Evaluation</measure>
    <time_frame>10 and 30 days post wound closure</time_frame>
    <description>assessment of the quality of wound healing by the physician.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Laceration of Skin</condition>
  <arm_group>
    <arm_group_label>BandGrip</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Topical skin closure device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Suture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard sutures will be used for wound closure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BandGrip</intervention_name>
    <description>Topical skin closure device</description>
    <arm_group_label>BandGrip</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Suture</intervention_name>
    <description>Wound closure</description>
    <arm_group_label>Standard Suture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male/Female age 18-65.&#xD;
&#xD;
          -  Subject presents to emergency room with at least one skin laceration that is assessed&#xD;
             as requiring a suture closure on the trunk or extremities (excluding hands and feet).&#xD;
&#xD;
          -  The length of the laceration is less than or equal to 1.5 inches.&#xD;
&#xD;
          -  Subject is otherwise in good general health in the opinion of the investigator.&#xD;
&#xD;
          -  Subject must be willing to follow instructions for wound care provided by investigator&#xD;
             and refrain from picking at the treatment device, applying topical medications to the&#xD;
             wound, and swimming or soaking in a tub until BandGrip or the sutures are removed.&#xD;
&#xD;
          -  Subject agrees to return for follow-up evaluations.&#xD;
&#xD;
          -  Subject (or guardian) is able to comprehend and give informed consent for&#xD;
             participation in this study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant multiple trauma (merely multiple wounds are allowed).&#xD;
&#xD;
          -  The wound involves a lower limb with critical limb ischemia.&#xD;
&#xD;
          -  Concurrent acute infection requiring intravenous or oral antibiotics.&#xD;
&#xD;
          -  Bleeding, coagulation and or clotting disorders.&#xD;
&#xD;
          -  Subject is on dialysis.&#xD;
&#xD;
          -  Inflammatory and or allergic diseases or conditions of the skin: for example,&#xD;
             psoriasis, eczema or dermatitis.&#xD;
&#xD;
          -  History of drug abuse.&#xD;
&#xD;
          -  Chronic use of oral steroids or immunosuppressants.&#xD;
&#xD;
          -  Known personal or family history of keloid or hypertrophic scarring.&#xD;
&#xD;
          -  History of abnormal wound healing.&#xD;
&#xD;
          -  Burst stellate lacerations due to a crush or hard blow.&#xD;
&#xD;
          -  Animal or human bite or scratch.&#xD;
&#xD;
          -  Wound is in the head, hands or feet or in a high skin tension area or across an area&#xD;
             of increased skin tension on a joint.&#xD;
&#xD;
          -  Investigator objects to a patient's involvement in the study protocol.&#xD;
&#xD;
          -  Known allergy to components to BandGrip or suture material.&#xD;
&#xD;
          -  Known cognitive or psychiatric disorder.&#xD;
&#xD;
          -  Wound requiring debridement of devitalized or contaminated tissue.&#xD;
&#xD;
          -  Wound at site of active rash/skin lesion making evaluation difficult.&#xD;
&#xD;
          -  Previously treated wound or has failed to heal.&#xD;
&#xD;
          -  Puncture wound.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dennis Donohoe</last_name>
    <role>Study Director</role>
    <affiliation>BandGrip</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dennis J Donohoe, MD</last_name>
    <phone>215-499-4458</phone>
    <email>ddonohoeconsult@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Irvine</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Fox, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 18, 2018</study_first_submitted>
  <study_first_submitted_qc>August 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>July 8, 2019</last_update_submitted>
  <last_update_submitted_qc>July 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lacerations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

